Rifampin (Rifadin) and Ketamine Therapy | Tovani Health
Rifadin (Rifampin) (also: Rimactane) — Antimycobacterial antibiotic (potent CYP3A4 inducer)
Verdict at Tovani Health
Strong CYP3A4 induction can substantially lower ketamine exposure; we plan around the course.
Rifampin alongside ketamine requires individual evaluation. Rifampin is the prototypical strong CYP3A4 inducer in clinical use, similar in magnitude to carbamazepine. Patients on rifampin (typically for TB or specific Gram-positive infections) may experience meaningfully reduced ketamine exposure and blunted response. We do not refuse, but we plan honestly: response may be smaller during therapy, with normalization in the weeks after the course finishes.
If you take Rifadin regularly and are considering at-home ketamine therapy, the combination is depends on your specific situation. This page covers the brief pharmacologic context and what we do at intake.
How Rifadin interacts with ketamine
Rifampin strongly induces CYP3A4, CYP2B6, CYP2C9, and P-glycoprotein. Ketamine relies on CYP3A4 and CYP2B6 for clearance, so induction increases clearance and lowers plasma exposure for any given dose. Effect persists 1-2 weeks after the last rifampin dose.
What we do at intake
Disclose current or recent rifampin therapy. Tell us the indication and duration. We may delay starting KAP until at least 2 weeks after the course finishes for the most predictable response.
Bottom line
Rifampin alongside ketamine requires individual evaluation. Rifampin is the prototypical strong CYP3A4 inducer in clinical use, similar in magnitude to carbamazepine. Patients on rifampin (typically for TB or specific Gram-positive infections) may experience meaningfully reduced ketamine exposure and blunted response. We do not refuse, but we plan honestly: response may be smaller during therapy, with normalization in the weeks after the course finishes.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Rifadin (Rifampin) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Sources
The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthetic and Pain Therapy. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Clinical Pharmacokinetics. 2016. PMID: 27028535
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 17, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.